Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Neurocrine Bioscienc (NQ: NBIX )

93.92 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 93.92
Bid (Size) 91.42 (1)
Ask (Size) 96.93 (1)
Prev. Close 93.92
Today's Range 93.92 - 93.92
52wk Range 86.02 - 126.71
Shares Outstanding 94,545,991
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
Conference Call and Webcast Scheduled for Tuesday, August 3 
From PR Newswire
Neurocrine Biosciences to Participate at the William Blair Biotech Focus Conference
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Kyle Gano, Chief Business Development and Strategy Officer, will participate in a neuropsychology-focused panel discussion at the... 
From PR Newswire

Performance

YTD
-2.03%
-2.03%
1 Month
-4.48%
-4.48%
3 Month
-3.87%
-3.87%
6 Month
-15.23%
-15.23%
1 Year
-22.79%
-22.79%

More News

Read More
Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
From PR Newswire
Neurocrine Biosciences to Present at the 2021 RBC Global Healthcare Conference
From PR Newswire
Neurocrine Biosciences Reports First Quarter 2021 Financial Results
From PR Newswire
Parkinson’s Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Parkinson's Disease Therapeutic Market Revenue Is Expected To Cross $8 Billion By 2027
From PR Newswire
Neurocrine Biosciences to Present at the Bank of America 2021 Healthcare Conference
From PR Newswire
Neurocrine Biosciences Supports Mental Health Month and Tardive Dyskinesia Awareness Week
From PR Newswire
Sentia Medical Sciences and Neurocrine Biosciences Enter into Strategic Collaboration to Discover Novel CRF Peptides
From GlobeNewswire News Releases
Biotechs Aligning to Address Challenges for Developing Therapeutics for Billion Dollar Neurological Disorders Industry
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.